Distell and Invenfin move into cannabis
The two companies paid undisclosed amounts to each buy a 20% stake in Releaf Pharmaceuticals
20 January 2021 - 19:06
Wine, cider and spirits group Distell, and Invenfin, the venture capital arm of its holding company Remgro, have made a new investment into a cannabis company to take advantage of the fast-growing sector.
The two companies paid undisclosed amounts to each buy a 20% stake in Releaf Pharmaceuticals, a new business that sells oils and tea infused with cannabis under the brand Rethink CBD...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.